XJPX
3172
Market cap30mUSD
Oct 09, Last price
1,125.00JPY
1D
-0.18%
1Q
-3.10%
Jan 2017
-19.76%
IPO
110.67%
Name
Tea Life Co Ltd
Chart & performance
P/E
21.56
P/S
0.43
EPS
52.18
Div yield, %
3.55%
Shrs. gr., 5y
0.11%
Rev. gr., 5y
-1.01%
Revenues
11.14b
-3.14%
Net income
223m
-37.71%
CFO
87m
-83.46%
Dividend
Jan 28, 202715 JPY/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Tea Life Co., Ltd. operates in Japan, primarily marketing a variety of products such as health teas, nutritional supplements, beauty items, and pharmaceuticals through its online and mail-order catalog channels. The company, which established its operations in 1983, maintains its principal office in Shimada, Japan.
Key people
Kazuya Ito
Director of Operations in Logistics Company Center, Director · since 2023
Takashi Kusama
Chief Director of EC & Overseas Business, Director of EC Business, Director of Overseas Business, Director · since 2018
Hirokazu Ishizawa
Director of Sales in Logistics Company, Manager of Logistics Company, Director · since 2023
Masao Kojima
Chief Director of Group, Director · since 2023
Setsuya Nishigami
President, Manager of Life Support Company, Manager of Logistics Company, Representative Director · since 2023
Akira Okamura
Director · since 2020
Masakazu Saito
Director of Management Service Company Administration, Chief Director of Corporate, Director of Corporate Business Strategy, Manager of Management Service Company, Director · since 2023
Nobuji Ueda
Director · since 2022
Rieko Iwai
Independent Director · since 2022
Toshiko Terada
Independent Director · since 2022
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026‑07 | 2025‑07 | 2024‑07 | 2023‑07 | 2022‑07 | 2021‑07 | 2020‑07 | 2019‑07 | 2018‑07 | 2017‑07 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||